Teva Delivers First US Forteo Equivalent
Approved Teriparatide Generic Is Slated To Launch ‘In The Coming Weeks’
Executive Summary
Teva has celebrated a US nod for its generic version of Forteo, the first substitutable teriparatide rival to be approved by the US Food and Drug Administration.